GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2026)

GeneDx Holdings (WGS) has reported Total Non-Current Liabilities for 7 consecutive years, with $237.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 29.29% year-over-year to $237.2 million in Q2 2026; TTM through Jun 2026 was $237.2 million, a 29.29% increase from a year earlier, with the FY2025 full-year figure at $213.9 million, up 26.85% from the prior year.
• Total Non-Current Liabilities was $237.2 million for Q2 2026 at GeneDx Holdings, down from $252.1 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $288.7 million in Q2 2022 and troughed at $140.4 million in Q3 2023.
• A 5-year average of $198.8 million and a median of $187.8 million in 2022 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 63.96% in 2022, down 51.89% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $213.2 million in 2022, then retreated by 17.45% to $176.0 million in 2023, then dropped by 4.2% to $168.6 million in 2024, then advanced by 26.85% to $213.9 million in 2025, then grew by 10.9% to $237.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $237.2 million (Q2 2026), $252.1 million (Q1 2026), and $213.9 million (Q4 2025), per Business Quant data.